ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Revenue

In the year 2025, ACADIA Pharmaceuticals had annual revenue of $1.07B with 11.87% growth. ACADIA Pharmaceuticals had revenue of $283.99M in the quarter ending December 31, 2025, with 9.39% growth.

• Revenue (ttm): $1.07B
• Revenue Growth: +11.87%
• P/S Ratio: 3.55
• Revenue / Employee: $1,342,738
• Employees: 798
• Market Cap: 3.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.07B	113.71M	11.87%
Dec 31, 2024	957.80M	231.36M	31.85%
Dec 31, 2023	726.44M	209.20M	40.45%
Dec 31, 2022	517.24M	33.09M	6.83%
Dec 31, 2021	484.15M	42.39M	9.60%
Dec 31, 2020	441.76M	102.68M	30.28%
Dec 31, 2019	339.08M	115.27M	51.50%
Dec 31, 2018	223.81M	98.91M	79.19%
Dec 31, 2017	124.90M	107.57M	620.68%
Dec 31, 2016	17.33M	17.27M	28,311.48%
Dec 31, 2015	61.00K	-59.00K	-49.17%
Dec 31, 2014	120.00K	-1.03M	-89.52%
Dec 31, 2013	1.15M	-3.76M	-76.67%
Dec 31, 2012	4.91M	2.84M	137.40%
Dec 31, 2011	2.07M	-40.07M	-95.09%
Dec 31, 2010	42.14M	35.74M	558.46%
Dec 31, 2009	6.40M	4.81M	302.45%
Dec 31, 2008	1.59M	-5.97M	-78.95%
Dec 31, 2007	7.56M	-578.00K	-7.11%
Dec 31, 2006	8.13M	-2.82M	-25.77%
Dec 31, 2005	10.96M	-	-

Data Source: Fiscal.ai Last updated: Feb 26, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error